Page last updated: 2024-12-06

sydnophen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

sydnophen: RN given refers to parent cpd; structure in Negwer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72088
CHEMBL ID2104320
SCHEMBL ID728995
MeSH IDM0060887

Synonyms (23)

Synonym
feprosidnine
sydnophen
3-(1-phenylpropan-2-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine
AKOS005267148
22293-47-6
[3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl]azanide
3-(1-methyl-2-phenylethyl)sydnone imine, monohydrochloride
feprosidninum
3-(alpha-methylphenethyl)sydnone imine
feprosidnine [inn]
feprosidninum [inn-latin]
feprosidnina
feprosidnina [inn-spanish]
unii-1g4w8nr1pt
1g4w8nr1pt ,
FT-0683010
3-(.alpha.-methylphenethyl)sydnone imine
CHEMBL2104320
SCHEMBL728995
5-azanidyl-3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium
Q4482905
1,2,3-oxadiazolium, 5-amino-3-(1-methyl-2-phenylethyl)-, inner salt
DTXSID801027235

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Analysis of dose-response NA action has indicated that sydnophen enhances adrenoceptor sensitivity (the dissociation constant changes from 10."( [Sidnofen-dependent pre- and postsynaptic activation of peripheral adrenergic transmission].
Babskaia, NE,
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]